A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2
Selecting an appropriate oral contraceptive can be challenging for healthcare professionals due to the abundance of marketed contraceptive options with different clinical and real-world effectiveness and safety profiles. Nomegestrol acetate + 17β-estradiol (NOMAC/E2) is a combined oral contraceptive...
Saved in:
Main Authors: | Franca Fruzzetti (Author), Rogerio Bonassi Machado (Author), Iñaki Lete (Author), Amisha Patel (Author), Mitra Boolell (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study
by: Sophia von Stockum, et al.
Published: (2023) -
NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study
by: Sophia von Stockum, et al.
Published: (2023) -
Hormonal Contraceptives and Risk of Breast Cancer: How to Explain it without Controversy
by: Rogério Bonassi Machado
Published: (2018) -
Real-world experience of women using extended-cycle vs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey
by: Rossella E. Nappi, et al.
Published: (2018) -
Contraceptive counseling during the pandemic: practical guidelines
by: Edson Santos Ferreira Filho, et al.
Published: (2021)